Targeting BUB3 in combination with paclitaxel inhibits proliferation of glioblastoma cells by enhancing cellular senescence. RevSALUS [Internet]. 6 de Abril de 2022 [citado 8 de Maio de 2026];4(Sup):37. Disponível em: https://revsalus.com/index.php/RevSALUS/article/view/267